It was a wild last few years for gold and for a fund I've covered twice before now , the WisdomTree Efficient Gold Plus Gold Miners ETF ( GDMN ). I'll get into the mechanics later, but essentially the fund is aWriter | Investment Advisor | Economics Wonk | Top 5% on TipRanks | Long Signal, Short Noise | Author of The Macro Obsession, a weekly newsletter on current events and trends in finance, tech, and the real economy. My work focuses on my quest to uncover narrative trends before mainstream financial med ...

Analyst’s Disclosure: I/we have a beneficial long position in the shares of WPP, OMC, PUBGY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. While this article may sound like financial advice, please observe that the author is not a CFA or in any way licensed to give fina ...

分组1 - NVIDIA Corporation's Q4 '25 earnings showed a remarkable revenue increase of 73% to $68.1 billion [1] - Gross margins expanded by 200 basis points to 75%, indicating no pricing pressure [1] - Operating expenses also increased, although specific figures were not provided [1]

Core Insights - Neurizon Therapeutics has initiated dosing of its lead candidate NUZ-001 in the HEALEY ALS Platform Trial, marking a significant milestone in the development of treatments for amyotrophic lateral sclerosis (ALS) [1][2] Company Overview - Neurizon Therapeutics Limited is a clinical-stage biotechnology company focused on advancing innovative treatments for neurodegenerative diseases, particularly ALS [1] - The company aims to accelerate access to effective ALS treatments while exploring broader applications for NUZ-001 in neurodegenerative disorders [1] Clinical Trial Details - The HEALEY ALS Platform Trial is a multicenter, double-blind, placebo-controlled adaptive Phase 2/3 clinical trial designed to evaluate multiple investigational drugs concurrently [1][2] - Approximately 160 participants with ALS will be enrolled in a 36-week randomized, double-blind, placebo-controlled trial, with a primary objective to assess the efficacy of NUZ-001 compared to placebo [1] - The trial is conducted by the Sean M. Healey & AMG Center for ALS at Mass General Hospital Brigham, in collaboration with the Network of Excellence for ALS (NEALS) [1] Study Design and Objectives - Regimen I of the trial includes a randomized controlled treatment phase followed by an active treatment extension phase, both lasting 36 weeks [1] - Participants will receive either daily NUZ-001 at a dose of 10 mg/kg or a placebo at a 3:1 ratio [1] - Secondary objectives include additional measures of disease progression and safety [1] Infrastructure and Collaboration - The HEALEY ALS Platform Trial leverages shared infrastructure across over 70 clinical sites, enhancing trial efficiency and data generation [1][2] - The trial's design allows for streamlined start-up and enrollment processes, facilitating faster results and ongoing engagement with regulatory authorities, including the FDA [1] Leadership Commentary - The Principal Investigator, Professor Merit Cudkowicz, emphasized the significance of the trial's initiation and the collaboration with Neurizon [1] - Neurizon's Managing Director, Dr. Michael Thurn, highlighted the trial as a registrational study aimed at generating clinical evidence for potential regulatory submissions [1]

7,472,300+$15.12+7.90%$206.62[GoDaddy][GDDY]• Vol: 3,849,474+$5.67+7.17%$84.79## Top Losing Stocks[Universal Health Services][UHS]• Vol: 1,118,971-$25.4811.04%$205.25[Corning][GLW]• Vol: 14,527,219-$10.706.67%$149.74[Albemarle][ALB]• Vol: 1,735,540-$11.415.82%$184.47[First Solar] [FSLR]• Vol: 3,751,568-$12.115.76%$198.01[NVIDIA][NVDA]• Vol: Overall Grade: B+ - Synopsys beat on both revenue and earnings, with the Ansys…]## HP Inc. Earnings Preview: What Wall Street Is Watching[Joel South | Feb 24, 2026 at 1: ...

That release could not be found. ...

The archived webcast will be available for one year following the event. Additionally, an investor slide presentation will be available beginning Monday, March 2, 2026, at www.ubsi-inc.com. United Bankshares, Inc. is a financial services company with consolidated assets of approximately $34 billion as of December 31, 2025. It is the parent company of United Bank, which comprises over 240 offices located across Washington, D.C., Virginia, West Virginia, Maryland, North Carolina, South Carolina, Ohio, Pennsyl ...

"By prioritizing efficiencies and thoughtful change, we can continue to focus to what matters most—our people and the customers and communities we serve.†- Beth Ryan, Vice President Senior Retail Operations Manager Share SANTA ROSA, Calif.--(BUSINESS WIRE)--Exchange Bank (OTC: EXSR) is pleased to announce the promotion of Beth Ryan from Vice President, Community Engagement Officer to Vice President Senior Retail Operations Manager, reflecting her more than three decades of leadership, service, and deep comm ...

Stay Informed: Never Miss a Notification from American Water [Accessibility Statement] Skip NavigationCustomers should update contact information now to help ensure receipt of emergency and general service alertsCAMDEN, N.J., Feb. 26, 2026 /PRNewswire/ -- American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., urges customers to update their contact information through its [online customer portal, MyWater], in order to receive notifications about emergency alerts ...

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Franklin BSP Realty Trust, Inc. ("Franklin†or the "Company†) (NYSE: FBRT) and reminds investors of the April 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. To learn more about the Franklin BSP Realty Trust class action, go to www.faruqilaw.com/FBRT or call Faruqi & Faruqi partner Josh Wilson di ...